Abstract
A modified synthetic route to combretastatin D-2 (5) was devised in order to further evaluate its biological activity, for its conversion to phosphate prodrugs (25-28), and as a route to obtaining dihydro-combretastatin D-2 (42). A parallel first total synthesis of dihydro-combretastatin D-2 was completed, proceeding from a saturated 3-phenylpropionic ester intermediate via the Ullmann biaryl ether reaction (39-41). In contrast to the cancer cell growth inhibitory activity exhibited by combretastatin D-2, relatively minor structural modifications (41, 42) caused elimination of those properties.
Original language | English (US) |
---|---|
Pages (from-to) | 876-883 |
Number of pages | 8 |
Journal | Journal of Natural Products |
Volume | 72 |
Issue number | 5 |
DOIs | |
State | Published - May 22 2009 |
ASJC Scopus subject areas
- Analytical Chemistry
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Complementary and alternative medicine
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2'. Together they form a unique fingerprint.Datasets
-
CCDC 714059: Experimental Crystal Structure Determination
Pettit, G. R. (Creator), Quistorf, P. D. (Creator), Fry, J. A. (Creator), Herald, D. L. (Creator), Hamel, E. (Creator), Chapuis, J. (Creator) & Pettit, G. R. (Creator), The Cambridge Structural Database, 2010
DOI: 10.5517/ccrz15x, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccrz15x&sid=DataCite
Dataset